Rancho BioSciences Launches OmicsHQ for AI Drug Discovery
SAN DIEGO, Calif., May 19, 2026 Rancho BioSciences has officially launched OmicsHQ™, a comprehensive and expertly curated multi-omics data...
computational biology
Advertisement
Fathom Therapeutics Raises $47M to Advance AI Drug Design
NEW YORK, April 27, 2026 Fathom Therapeutics has announced the successful completion of an oversubscribed $47 million Series A...
Boehringer Ingelheim Expands AI Innovation Hub in UK
Ingelheim, Germany, April 20, 2026 Boehringer Ingelheim has announced a major strategic expansion of its computational innovation capabilities with...
Diagonal Therapeutics Secures $125M Series B to Advance Pipeline
CAMBRIDGE, Mass. | January 8, 2026 — Diagonal Therapeutics, a biotechnology company developing disease-modifying clustering antibody therapies, announced the...
AI Grant Aims to Boost Biologics Developability at Just – Evotec
SAN DIEGO | January 8, 2026 — Just – Evotec Biologics, a collaboration between Evotec SE and Just –...
Advertisements
Lantern Pharma Showcases AI Platforms to Accelerate Cancer Drug Discovery
Dallas, Texas, October 30, 2025 — Lantern Pharma Inc. (NASDAQ: LTRN) announced it will present two cutting-edge AI-driven drug-development...
Advertisement
